Chemotherapy

MADRID — Alectinib significantly improved DFS compared with chemotherapy alone in patients with resected ALK-positive non-small cell lung cancer, according to research presented at ESMO Congress 2023.

Researchers at The University of Texas MD Anderson Cancer Center have made improvements to hospital care pathways that reduced opioid use by 50% after pancreatic cancer surgery.

Researchers at UT Southwestern Medical Center have introduced a new metric that may be useful in predicting which patients are likely to develop immunotherapy toxicity.

The FDA approved pembrolizumab in combination with gemcitabine and cisplatin chemotherapy for adults with locally advanced unresectable or metastatic biliary tract cancer.

An implantable microdevice designed to test treatments in patients with gliomas during standard-of-care surgery has been easily and safely incorporated into surgical practice.

The offspring of adolescent and young adult women with a history of cancer experienced a higher risk for birth defects, according to study results published in Cancer Epidemiology, Biomarkers & Prevention.

Women who received anthracycline chemotherapy following a childhood cancer diagnosis are at an increased risk for subsequent breast cancer later in life, according to data published in Nature Medicine.

Osimertinib plus chemotherapy may benefit some lung cancer subsets compared with osimertinib alone, according to recent research from the FLAURA2 trial.

A study conducted at Dana-Farber Cancer Institute has shown that weighted blankets decreased anxiety during chemotherapy infusions when used as a supportive care measure, according to data presented at Oncology Nursing Society Congress.

Most U.S. cancer centers reported experiencing a shortage of at least one type of oncology drug, according to the results of a National Comprehensive Cancer Network survey on chemotherapy shortages.